Overview

Lubiprostone for Children With Constipation

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study is for children with constipation. Children who completed 3 months of treatment in the earlier study (NCT02042183): - were invited to participate - will receive lubiprostone for 9 more months - will see if lubiprostone safely relieves their constipation if taken for a whole year
Phase:
Phase 3
Details
Lead Sponsor:
Sucampo AG
Sucampo Pharma Americas, LLC
Collaborators:
Sucampo Pharma Americas, LLC
Takeda
Treatments:
Lubiprostone